Chavez-MacGregor M, Lei X, Zhao H, et al. - Researchers performed comparisons between patients with COVID-19 with or without cancer with respect to the rates of death, mechanical ventilation, intensive care unit stay, and hospitalization.

• Using the Optum de-identified COVID-19 electronic health record data set, a cohort study of more than 500,000 US adults who were diagnosed with COVID-19 was performed.

• Outcomes revealed an increased risk of death, intensive care unit admission, and hospitalization among patients with cancer who received anticancer treatment within 3 months before COVID-19 diagnosis.

• Similar or better outcomes were recorded for patients without recent cancer treatment when compared with those without cancer.

• Overall findings have risk stratification as well as resource use implications for patients, clinicians, and health systems.